Please login to the form below

Not currently logged in
Email:
Password:

David Epstein joins Flagship Pioneering as executive partner

He most recently served as CEO of Novartis Pharmaceuticals

Flagship Pioneering David EpsteinUS-based Flagship Pioneering has appointed former Novartis Pharmaceuticals chief executive David Epstein as its executive partner.

In this newly-created position, Epstein will begin working with Rubius Therapeutics, a red blood cell-focused exploratory venture within the Flagship portfolio, as chairman of its board.

He brings over 25 years of drug development, commercialisation and leadership experience within the pharmaceuticals industry, most recently as chief executive officer of Novartis Pharmaceuticals.

Prior to taking up this lead role in 2010, Epstein founded Novartis Oncology and Novartis Molecular Diagnostics in 1989, leading the start-up businesses as president and chief executive officer.

Dr Noubar Afeyan, founder and chief executive of Flagship, said: “David is a leader and long-time pioneer within the pharma industry, having developed dozens of new medicines benefiting millions of patients around the world.

“His progressive approach to science and business acumen gleaned over his tenured career in the pharmaceutical industry complements Flagship's culture and team.

“We will apply his expertise broadly as we continue making and realising the maximum potential of disruptive innovations that yield unprecedented therapies.”

25th January 2017

From: Research, Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

Covid-19 redefines rules of customer engagement
Oli Hudson, Content Director at Wilmington Healthcare, explores how the pandemic has changed pharma’s relationship with HCPs...
Ongoing Virtual Communication between MSLs and Physicians: a Customer Story
Learn how one of our clients used the Impetus InSite Platform to connect their MSLs with regional groups of physicians....
The concordance conundrum: understanding the complexities of behaviour change
Understanding behaviour change looks at the six fundamental steps required to change human behaviour and discusses why HCPs need to start here if concordance is to be improved....

Infographics